SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-12-001434
Filing Date
2012-04-26
Accepted
2012-04-26 16:48:31
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form20f.htm 20-F 758147
2 CERTIFICATE OF CONTINUATION DATED JUNE 22, 2011 exhibit1-1.htm EX-1.1 565
3 ARTICLES ADOPTED ON MAY 10, 2011 exhibit1-2.htm EX-1.2 162939
4 NOTICE OF ARTICLES DATED DECEMBER 5, 2011 exhibit1-3.htm EX-1.3 15481
5 SECTION 302 CERTIFICATION exhibit12-1.htm EX-12.1 6502
6 SECTION 302 CERTIFICATION exhibit12-2.htm EX-12.2 6583
7 SECTION 906 CERTIFICATION exhibit12-3.htm EX-12.3 2710
8 SECTION 906 CERTIFICATION exhibit12-4.htm EX-12.4 2655
9 GRAPHIC bdo.gif GRAPHIC 1373
10 GRAPHIC exhibit1-1x1x1.jpg GRAPHIC 53244
11 GRAPHIC exhibit1-3x1x1.jpg GRAPHIC 3849
12 GRAPHIC exhibit1-3x1x2.jpg GRAPHIC 2140
  Complete submission text file 0001062993-12-001434.txt   1040978
Mailing Address SUITE 1225 - 888 DUNSMUIR STREET VANCOUVER BC A1 V6C 3K4
Business Address SUITE 1225 - 888 DUNSMUIR STREET VANCOUVER BC A1 V6C 3K4 604-248-8730
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-50112 | Film No.: 12784237
SIC: 1040 Gold and Silver Ores